Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

VA Office of Research and Development · with Biomedical Advanced Research and Development Authority, Food and Drug Administration (FDA) · NCT06160128

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
400000
US sites recruiting
1
Study start
September 26, 2022
Record last updated
September 30, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to comprehensively describe the temporal and geographic utilization of COVID-19 therapies used for mild to moderate disease during different periods of SARS-CoV-2 variant circulation as well as to compare demographic and clinical characteristics of Veterans who are treated or do not receive these different therapies. The investigators will also perform similar descriptive epidemiology for other respiratory viruses, including RSV and influenza and other infectious diseases. This first phase will critically inform feasibility and direction of the second phase, in which the investigators will use target trial emulation design to study the comparative effectiveness of therapies and vaccines for COVID-19, respiratory viruses, including RSV, and influenza, and other infectious diseases.

Conditions: COVID-19, SARS-CoV-2 Infection; RSV; Influenza

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Phase 1:

  • Veterans with a laboratory-confirmed positive test for SARS-CoV-2 or a diagnosis of COVID-19 documented at any time since the beginning of the pandemic in January 2020 to present

Phase 2:

  • All Veterans alive and in Veterans Health Administration (VHA) care as of January 2018
  • Specific exclusion/inclusion criteria and observation periods will be further defined for each sub-study (See outcomes/publications)

Exclusion Criteria

  • VA employees who are not enrollees

Recruiting US locations

  • VA Portland Health Care System, Portland, OR

    Portland, OR 97207-2964

    Site contact: Kristina L Bajema, MD · (503) 220-8262 · Kristina.Bajema@va.gov

Study contacts (from the official record)

  • Kristina L Bajema, MD · (503) 220-8262 · Kristina.Bajema@va.gov
  • George N Ioannou, MD MS · (206) 277-3136 · George.Ioannou@va.gov
All healthy volunteers studies in Oregon →
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA… (NCT06160128) | Bored Studies